| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.00086 | 1 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.00081 | 1 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.00098 | 1 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.00059 | 1 |